Susan Dent
ScholarGPS® ID: 96015269467607
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Breast Cancer | Chemotherapy | Metastatic Breast Cancer | Trastuzumab | Estrogen Deprivation Therapy | Adjuvant Therapy | Heart Failure | Bone Metastasis | Epidermal Growth Factor | Epidermal Growth Factor Receptor | Growth Factor Receptor | Hormone | Targeted Therapy | COVID-19
Metrics Summary
Publication Count
231
Predicted Citations
10,453
Predicted h-index
47
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study (journal article) The American Journal of Cardiology, volume 222 (2024). |
Breast cancer risk reduction: Beyond pharmacologic intervention (journal article) Cancer (2024). |
European Heart Journal, volume 45, issue 22, pages 1971-1987 (2024). |
The immunomodulatory impacts of endocrine therapy on host immunity in early-stage hormone receptor positive, HER2 negative breast cancer. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 572-572 (2024). |
Breast Cancer Research and Treatment (2024). |
Coverage for evidence-based cancer survivorship care services (journal article) Supportive Care in Cancer, volume 32, issue 3 (2024). |
Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study (journal article) American Heart Journal, volume 267 (2024). |
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction (journal article) JACC: Heart Failure, volume 12, issue 1, pages 67-78 (2024). |
Current Treatment Options in Cardiovascular Medicine, volume 26, issue 1, pages 1-12 (2024). |
Cardio-Oncology Rehabilitation Programs—The Next Phase in Improving Care for Cancer Survivors (journal article) JAMA Cardiology, volume 8, issue 12, pages 1128- (2023). |
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions (journal article) Journal of the American Heart Association, volume 12, issue 21 (2023). |
JACC: CardioOncology, volume 5, issue 5, pages 707-710 (2023). |
ER +, HER2 − advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes (journal article) Molecular Oncology, volume 17, issue 10, pages 2000-2016 (2023). |
The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011–22 (journal article) European Journal of Preventive Cardiology, volume 30, issue 13, pages 1325-1332 (2023). |
Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer (journal article) Cancers, volume 15, issue 18, pages 4630- (2023). |
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies (journal article) JACC: CardioOncology, volume 5, issue 4, pages 415-430 (2023). |
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer (journal article) Journal of the National Comprehensive Cancer Network, volume 21, issue 7, pages 705-714.e17 (2023). |
Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer (journal article) Journal of the American Heart Association, volume 12, issue 12 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages TPS12142-TPS12142 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e12618-e12618 (2023). |